Loading…

Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients

Background 18 F-FDG PET/CT is a key molecular imaging modality to noninvasively assess and differentiate benign and malignant cardiac tumors. However, few benign cardiac tumors can be characterized by increased 18 F-FDG uptake, which makes differential diagnosis difficult. This study sought to retro...

Full description

Saved in:
Bibliographic Details
Published in:EJNMMI research 2020-07, Vol.10 (1), p.75-75, Article 75
Main Authors: Liu, En-Tao, Sun, Tao-Tao, Dong, Hao-Jian, Wang, Si-Yun, Chen, Ze-Rui, Liu, Chao, Shao, Dan, Lian, Zhou-Yang, Xie, Qiu, Wang, Shu-Xia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3
cites cdi_FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3
container_end_page 75
container_issue 1
container_start_page 75
container_title EJNMMI research
container_volume 10
creator Liu, En-Tao
Sun, Tao-Tao
Dong, Hao-Jian
Wang, Si-Yun
Chen, Ze-Rui
Liu, Chao
Shao, Dan
Lian, Zhou-Yang
Xie, Qiu
Wang, Shu-Xia
description Background 18 F-FDG PET/CT is a key molecular imaging modality to noninvasively assess and differentiate benign and malignant cardiac tumors. However, few benign cardiac tumors can be characterized by increased 18 F-FDG uptake, which makes differential diagnosis difficult. This study sought to retrospectively evaluate whether combined 18 F-FDG PET/CT with thoracic contrast-enhanced CT (CECT) helps in assessing primary cardiac tumors in adult patients, compared with CECT or PET/CT alone. Methods Forty-six consecutive patients who were diagnosed as primary cardiac tumors were enrolled. All patients underwent 18 F-FDG PET/CT followed by thoracic CECT before biopsy or surgery. Visual qualitative interpretation and quantitative analysis were performed, and diagnostic performance was evaluated. Results More than half (16/29) of benign tumors exhibited with mild 18 F-FDG uptake. There were significant differences in 18 F-FDG uptake and the degree of absolute enhancement between benign and malignant tumors ( P < 0.001). The combination of two modalities improved the specificity from 79 to 93%, the positive predictive value from 73 to 89%, and the accuracy of diagnosis from 85 to 93%. There were significant differences between PET/CT alone or thoracic CECT alone and combined modalities ( P = 0.034 and P = 0.026, respectively). The combination with the optimal SUVmax cutoff value generated 94% sensitivity, 100% specificity, 97% negative predictive values, 100% positive predictive values, and 98% accuracy rates. Conclusions Combining 18 F-FDG PET/C with thoracic CECT significantly improved specificity and accuracy compared to CECT or PET/CT alone in detecting tumors. This combination of diagnostic imaging is effective in differentiating malignant from benign masses.
doi_str_mv 10.1186/s13550-020-00661-x
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c32512f56c2e44f79c6dd068a2aed0b9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c32512f56c2e44f79c6dd068a2aed0b9</doaj_id><sourcerecordid>2420335753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3</originalsourceid><addsrcrecordid>eNp9kkuLFDEUhQtRnGGcP-CqwI2bcvKopKo2gjSjDgzoogV34Sa51Z2mKmmTlI7_3vQDdVwY8iL5zuFyOVX1kpI3lPbyJlEuBGkIK4tISZuHJ9UlowNtyvb16V_3i-o6pR0pQ1Ax8P55dcGZPMzhsppWYdbOo60_365vVuv6h8vbOm9DBONMbYLPEVJu0G_Bm4IVxPkaUsKUZvS5DmO9j26G-LM2EK0DU-dlDjEdObtMud5DdgVNL6pnI0wJr8_nVfXl_e169bG5__ThbvXuvjGib3PTAW-ZtdDJVqAdhKAI3I6gtZaW4CitbGHkUmthOqREjkJDP_SyY9jTQfOr6u7kawPs1Lk6FcCp40OIGwUxOzOhMpwJykYhDcO2HbvBSGuJ7IEBWqKH4vX25LVf9IzW4KEh0yPTxz_ebdUmfFcd5z0ntBi8PhvE8G3BlNXsksFpAo9hSYq1jFLStYwV9NU_6C4s0ZdWHSjCuegELxQ7USaGlCKOv4uhRB2yoU7ZUCUb6pgN9VBE_CRKBfYbjH-s_6P6BcZnvPY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2420335753</pqid></control><display><type>article</type><title>Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><creator>Liu, En-Tao ; Sun, Tao-Tao ; Dong, Hao-Jian ; Wang, Si-Yun ; Chen, Ze-Rui ; Liu, Chao ; Shao, Dan ; Lian, Zhou-Yang ; Xie, Qiu ; Wang, Shu-Xia</creator><creatorcontrib>Liu, En-Tao ; Sun, Tao-Tao ; Dong, Hao-Jian ; Wang, Si-Yun ; Chen, Ze-Rui ; Liu, Chao ; Shao, Dan ; Lian, Zhou-Yang ; Xie, Qiu ; Wang, Shu-Xia</creatorcontrib><description>Background 18 F-FDG PET/CT is a key molecular imaging modality to noninvasively assess and differentiate benign and malignant cardiac tumors. However, few benign cardiac tumors can be characterized by increased 18 F-FDG uptake, which makes differential diagnosis difficult. This study sought to retrospectively evaluate whether combined 18 F-FDG PET/CT with thoracic contrast-enhanced CT (CECT) helps in assessing primary cardiac tumors in adult patients, compared with CECT or PET/CT alone. Methods Forty-six consecutive patients who were diagnosed as primary cardiac tumors were enrolled. All patients underwent 18 F-FDG PET/CT followed by thoracic CECT before biopsy or surgery. Visual qualitative interpretation and quantitative analysis were performed, and diagnostic performance was evaluated. Results More than half (16/29) of benign tumors exhibited with mild 18 F-FDG uptake. There were significant differences in 18 F-FDG uptake and the degree of absolute enhancement between benign and malignant tumors ( P &lt; 0.001). The combination of two modalities improved the specificity from 79 to 93%, the positive predictive value from 73 to 89%, and the accuracy of diagnosis from 85 to 93%. There were significant differences between PET/CT alone or thoracic CECT alone and combined modalities ( P = 0.034 and P = 0.026, respectively). The combination with the optimal SUVmax cutoff value generated 94% sensitivity, 100% specificity, 97% negative predictive values, 100% positive predictive values, and 98% accuracy rates. Conclusions Combining 18 F-FDG PET/C with thoracic CECT significantly improved specificity and accuracy compared to CECT or PET/CT alone in detecting tumors. This combination of diagnostic imaging is effective in differentiating malignant from benign masses.</description><identifier>ISSN: 2191-219X</identifier><identifier>EISSN: 2191-219X</identifier><identifier>DOI: 10.1186/s13550-020-00661-x</identifier><identifier>PMID: 32632639</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>18F-Fluorodeoxyglucose (18F-FDG) ; Accuracy ; Cardiac Imaging ; Diagnosis ; Diagnostic systems ; Fluorine isotopes ; Imaging ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Nuclear Medicine ; Oncology ; Original Research ; Orthopedics ; Performance evaluation ; PET/CT ; Positron emission ; Primary cardiac tumors ; Qualitative analysis ; Radiology ; Tomography ; Tomography, X-ray computed ; Tumors</subject><ispartof>EJNMMI research, 2020-07, Vol.10 (1), p.75-75, Article 75</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3</citedby><cites>FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3</cites><orcidid>0000-0003-4055-4844</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2420335753/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2420335753?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Liu, En-Tao</creatorcontrib><creatorcontrib>Sun, Tao-Tao</creatorcontrib><creatorcontrib>Dong, Hao-Jian</creatorcontrib><creatorcontrib>Wang, Si-Yun</creatorcontrib><creatorcontrib>Chen, Ze-Rui</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Shao, Dan</creatorcontrib><creatorcontrib>Lian, Zhou-Yang</creatorcontrib><creatorcontrib>Xie, Qiu</creatorcontrib><creatorcontrib>Wang, Shu-Xia</creatorcontrib><title>Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients</title><title>EJNMMI research</title><addtitle>EJNMMI Res</addtitle><description>Background 18 F-FDG PET/CT is a key molecular imaging modality to noninvasively assess and differentiate benign and malignant cardiac tumors. However, few benign cardiac tumors can be characterized by increased 18 F-FDG uptake, which makes differential diagnosis difficult. This study sought to retrospectively evaluate whether combined 18 F-FDG PET/CT with thoracic contrast-enhanced CT (CECT) helps in assessing primary cardiac tumors in adult patients, compared with CECT or PET/CT alone. Methods Forty-six consecutive patients who were diagnosed as primary cardiac tumors were enrolled. All patients underwent 18 F-FDG PET/CT followed by thoracic CECT before biopsy or surgery. Visual qualitative interpretation and quantitative analysis were performed, and diagnostic performance was evaluated. Results More than half (16/29) of benign tumors exhibited with mild 18 F-FDG uptake. There were significant differences in 18 F-FDG uptake and the degree of absolute enhancement between benign and malignant tumors ( P &lt; 0.001). The combination of two modalities improved the specificity from 79 to 93%, the positive predictive value from 73 to 89%, and the accuracy of diagnosis from 85 to 93%. There were significant differences between PET/CT alone or thoracic CECT alone and combined modalities ( P = 0.034 and P = 0.026, respectively). The combination with the optimal SUVmax cutoff value generated 94% sensitivity, 100% specificity, 97% negative predictive values, 100% positive predictive values, and 98% accuracy rates. Conclusions Combining 18 F-FDG PET/C with thoracic CECT significantly improved specificity and accuracy compared to CECT or PET/CT alone in detecting tumors. This combination of diagnostic imaging is effective in differentiating malignant from benign masses.</description><subject>18F-Fluorodeoxyglucose (18F-FDG)</subject><subject>Accuracy</subject><subject>Cardiac Imaging</subject><subject>Diagnosis</subject><subject>Diagnostic systems</subject><subject>Fluorine isotopes</subject><subject>Imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Research</subject><subject>Orthopedics</subject><subject>Performance evaluation</subject><subject>PET/CT</subject><subject>Positron emission</subject><subject>Primary cardiac tumors</subject><subject>Qualitative analysis</subject><subject>Radiology</subject><subject>Tomography</subject><subject>Tomography, X-ray computed</subject><subject>Tumors</subject><issn>2191-219X</issn><issn>2191-219X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kkuLFDEUhQtRnGGcP-CqwI2bcvKopKo2gjSjDgzoogV34Sa51Z2mKmmTlI7_3vQDdVwY8iL5zuFyOVX1kpI3lPbyJlEuBGkIK4tISZuHJ9UlowNtyvb16V_3i-o6pR0pQ1Ax8P55dcGZPMzhsppWYdbOo60_365vVuv6h8vbOm9DBONMbYLPEVJu0G_Bm4IVxPkaUsKUZvS5DmO9j26G-LM2EK0DU-dlDjEdObtMud5DdgVNL6pnI0wJr8_nVfXl_e169bG5__ThbvXuvjGib3PTAW-ZtdDJVqAdhKAI3I6gtZaW4CitbGHkUmthOqREjkJDP_SyY9jTQfOr6u7kawPs1Lk6FcCp40OIGwUxOzOhMpwJykYhDcO2HbvBSGuJ7IEBWqKH4vX25LVf9IzW4KEh0yPTxz_ebdUmfFcd5z0ntBi8PhvE8G3BlNXsksFpAo9hSYq1jFLStYwV9NU_6C4s0ZdWHSjCuegELxQ7USaGlCKOv4uhRB2yoU7ZUCUb6pgN9VBE_CRKBfYbjH-s_6P6BcZnvPY</recordid><startdate>20200706</startdate><enddate>20200706</enddate><creator>Liu, En-Tao</creator><creator>Sun, Tao-Tao</creator><creator>Dong, Hao-Jian</creator><creator>Wang, Si-Yun</creator><creator>Chen, Ze-Rui</creator><creator>Liu, Chao</creator><creator>Shao, Dan</creator><creator>Lian, Zhou-Yang</creator><creator>Xie, Qiu</creator><creator>Wang, Shu-Xia</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>SpringerOpen</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4055-4844</orcidid></search><sort><creationdate>20200706</creationdate><title>Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients</title><author>Liu, En-Tao ; Sun, Tao-Tao ; Dong, Hao-Jian ; Wang, Si-Yun ; Chen, Ze-Rui ; Liu, Chao ; Shao, Dan ; Lian, Zhou-Yang ; Xie, Qiu ; Wang, Shu-Xia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>18F-Fluorodeoxyglucose (18F-FDG)</topic><topic>Accuracy</topic><topic>Cardiac Imaging</topic><topic>Diagnosis</topic><topic>Diagnostic systems</topic><topic>Fluorine isotopes</topic><topic>Imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Research</topic><topic>Orthopedics</topic><topic>Performance evaluation</topic><topic>PET/CT</topic><topic>Positron emission</topic><topic>Primary cardiac tumors</topic><topic>Qualitative analysis</topic><topic>Radiology</topic><topic>Tomography</topic><topic>Tomography, X-ray computed</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, En-Tao</creatorcontrib><creatorcontrib>Sun, Tao-Tao</creatorcontrib><creatorcontrib>Dong, Hao-Jian</creatorcontrib><creatorcontrib>Wang, Si-Yun</creatorcontrib><creatorcontrib>Chen, Ze-Rui</creatorcontrib><creatorcontrib>Liu, Chao</creatorcontrib><creatorcontrib>Shao, Dan</creatorcontrib><creatorcontrib>Lian, Zhou-Yang</creatorcontrib><creatorcontrib>Xie, Qiu</creatorcontrib><creatorcontrib>Wang, Shu-Xia</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>EJNMMI research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, En-Tao</au><au>Sun, Tao-Tao</au><au>Dong, Hao-Jian</au><au>Wang, Si-Yun</au><au>Chen, Ze-Rui</au><au>Liu, Chao</au><au>Shao, Dan</au><au>Lian, Zhou-Yang</au><au>Xie, Qiu</au><au>Wang, Shu-Xia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients</atitle><jtitle>EJNMMI research</jtitle><stitle>EJNMMI Res</stitle><date>2020-07-06</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>75</spage><epage>75</epage><pages>75-75</pages><artnum>75</artnum><issn>2191-219X</issn><eissn>2191-219X</eissn><abstract>Background 18 F-FDG PET/CT is a key molecular imaging modality to noninvasively assess and differentiate benign and malignant cardiac tumors. However, few benign cardiac tumors can be characterized by increased 18 F-FDG uptake, which makes differential diagnosis difficult. This study sought to retrospectively evaluate whether combined 18 F-FDG PET/CT with thoracic contrast-enhanced CT (CECT) helps in assessing primary cardiac tumors in adult patients, compared with CECT or PET/CT alone. Methods Forty-six consecutive patients who were diagnosed as primary cardiac tumors were enrolled. All patients underwent 18 F-FDG PET/CT followed by thoracic CECT before biopsy or surgery. Visual qualitative interpretation and quantitative analysis were performed, and diagnostic performance was evaluated. Results More than half (16/29) of benign tumors exhibited with mild 18 F-FDG uptake. There were significant differences in 18 F-FDG uptake and the degree of absolute enhancement between benign and malignant tumors ( P &lt; 0.001). The combination of two modalities improved the specificity from 79 to 93%, the positive predictive value from 73 to 89%, and the accuracy of diagnosis from 85 to 93%. There were significant differences between PET/CT alone or thoracic CECT alone and combined modalities ( P = 0.034 and P = 0.026, respectively). The combination with the optimal SUVmax cutoff value generated 94% sensitivity, 100% specificity, 97% negative predictive values, 100% positive predictive values, and 98% accuracy rates. Conclusions Combining 18 F-FDG PET/C with thoracic CECT significantly improved specificity and accuracy compared to CECT or PET/CT alone in detecting tumors. This combination of diagnostic imaging is effective in differentiating malignant from benign masses.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32632639</pmid><doi>10.1186/s13550-020-00661-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4055-4844</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2191-219X
ispartof EJNMMI research, 2020-07, Vol.10 (1), p.75-75, Article 75
issn 2191-219X
2191-219X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c32512f56c2e44f79c6dd068a2aed0b9
source Open Access: PubMed Central; Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access
subjects 18F-Fluorodeoxyglucose (18F-FDG)
Accuracy
Cardiac Imaging
Diagnosis
Diagnostic systems
Fluorine isotopes
Imaging
Medical imaging
Medicine
Medicine & Public Health
Nuclear Medicine
Oncology
Original Research
Orthopedics
Performance evaluation
PET/CT
Positron emission
Primary cardiac tumors
Qualitative analysis
Radiology
Tomography
Tomography, X-ray computed
Tumors
title Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20PET/CT%20with%20thoracic%20contrast-enhanced%20CT%20in%20assessment%20of%20primary%20cardiac%20tumors%20in%20adult%20patients&rft.jtitle=EJNMMI%20research&rft.au=Liu,%20En-Tao&rft.date=2020-07-06&rft.volume=10&rft.issue=1&rft.spage=75&rft.epage=75&rft.pages=75-75&rft.artnum=75&rft.issn=2191-219X&rft.eissn=2191-219X&rft_id=info:doi/10.1186/s13550-020-00661-x&rft_dat=%3Cproquest_doaj_%3E2420335753%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c584t-7a342dda7645ed9551ea3dfabbb6d0ef6d64af36bb5c7e106f5ba898672e819b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2420335753&rft_id=info:pmid/32632639&rfr_iscdi=true